Standout Papers
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (2010)
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion (2012)
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center (2015)
- Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma (1999)
- Evolutionary dynamics of cancer in response to targeted combination therapy (2013)
- Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting (2010)
Immediate Impact
20 by Nobel laureates 41 from Science/Nature 124 standout
Citing Papers
Cutaneous melanoma
2023 Standout
Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
Works of Paul B. Chapman being referenced
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
2012 StandoutNature
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Paul B. Chapman | 8418 | 8926 | 4090 | 229 | 15.2k | |
| Igor Puzanov | 6732 | 10021 | 3784 | 300 | 15.1k | |
| Steven O’Day | 4675 | 9336 | 4551 | 195 | 12.6k | |
| Adil Daud | 7252 | 10082 | 5088 | 308 | 15.7k | |
| Alexander M. Menzies | 5005 | 9505 | 3093 | 326 | 12.1k | |
| Richard Kefford | 11485 | 13685 | 3916 | 353 | 20.1k | |
| Michele Maio | 7186 | 11151 | 6794 | 371 | 18.0k | |
| Boris C. Bastian | 12333 | 11775 | 3327 | 199 | 20.3k | |
| Douglas B. Johnson | 4462 | 9445 | 3922 | 289 | 13.5k | |
| Matteo S. Carlino | 4588 | 9269 | 3616 | 299 | 12.0k | |
| Axel Hauschild | 9848 | 12970 | 4217 | 428 | 20.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...